NSPR Message Board Post 9275024 | InspireMD Inc.
home / stock / nspr / nspr message board
Cbp507
(investorshub)
Posted on: Jun/09/2021 19:23:48
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164299580
some conference today, looks like 'someone' likes what
News, Short Squeeze, Breakout and More Instantly...
-
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...
-
- Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of 2023 - - Announced that an abstract detailing one-year outcomes from the C-GUARDIANS IDE clinical trial of CGuard™ Prime has been accepted for presentation at LINC 2...